Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IBBQ vs. BIB: which is better?

Bottom line

IBBQ vs BIB: the short answer

IBBQ (Invesco Nasdaq Biotechnology ETF) and BIB (ProShares Ultra Nasdaq Biotechnology) share a meaningful slice of their top holdings — about 51% by weight.

IBBQ is cheaper at 0.19% vs 0.95% — a difference of $76 a year per $10,000 invested.

Over one year, BIB returned +59.3% vs −0.6% for IBBQ (reporting dates differ).

Updated Nov 19, 2026

IBBQ vs BIB side by side

IBBQBIB
TypeETFETF
Fund familyInvescoProShares
CategoryTechnology SectorTechnology Sector
Expense ratio0.19%0.95%
Annual cost per $10k$19$95
10-yr cost on $10k (prospectus)$242$1,401
Max front loadNoneNone
12b-1 fee——
1-yr return−0.6%+59.3%
5-yr return (annualized)—−1.0%
10-yr return (annualized)—+1.4%
Best quarter+12.0%+56.2%
Worst quarter−11.7%−42.7%
Net assets (fund)$67.4M$73.7M
Number of holdings261267
Portfolio turnover17%29%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIBBQBIBDifference
2024−0.6%−10.0%+9.4%
2023+4.5%−1.3%+5.8%
2022−10.2%−28.6%+18.4%

Source: Fund prospectus bar charts

Holdings overlap

15 of IBBQ's top 25 holdings also appear in BIB's top 25.

Shared top holdings
HoldingIBBQBIB
Gilead Sciences, Inc.7.39%4.66%
Vertex Pharmaceuticals Inc.7.38%4.65%
Amgen Inc.7.10%4.48%
Regeneron Pharmaceuticals, Inc.5.08%3.21%
Alnylam Pharmaceuticals, Inc.3.19%2.01%
Revolution Medicines, Inc.2.48%1.57%
Biogen Inc.2.29%1.44%
Illumina, Inc.1.98%1.25%
United Therapeutics Corp.1.94%1.22%
argenx SE1.89%1.19%
Insmed Inc.1.83%1.16%
Incyte Corp.1.53%0.97%
Viatris Inc.1.49%0.94%
Moderna, Inc.1.48%0.94%
Guardant Health, Inc.1.35%0.85%

Source: SEC Form N-PORT

IBBQ top 10

  1. Invesco Private Prime Fund — 14.20%
  2. Gilead Sciences, Inc. — 7.39%
  3. Vertex Pharmaceuticals Inc. — 7.38%
  4. Amgen Inc. — 7.10%
  5. Invesco Private Government Fund — 5.48%
  6. Regeneron Pharmaceuticals, Inc. — 5.08%
  7. Alnylam Pharmaceuticals, Inc. — 3.19%
  8. Revolution Medicines, Inc. — 2.48%
  9. Biogen Inc. — 2.29%
  10. Illumina, Inc. — 1.98%

BIB top 10

  1. N/a — 7.35%
  2. ProShares GENIUS Money Market ETF — 6.80%
  3. Gilead Sciences, Inc. — 4.66%
  4. Vertex Pharmaceuticals, Inc. — 4.65%
  5. Amgen, Inc. — 4.48%
  6. N/a — 3.94%
  7. N/a — 3.26%
  8. Regeneron Pharmaceuticals, Inc. — 3.21%
  9. N/a — 2.62%
  10. Alnylam Pharmaceuticals, Inc. — 2.01%

FAQ

What is the difference between IBBQ and BIB?
IBBQ (Invesco Nasdaq Biotechnology ETF) and BIB (ProShares Ultra Nasdaq Biotechnology) share a meaningful slice of their top holdings — about 51% by weight. IBBQ is cheaper at 0.19% vs 0.95% — a difference of $76 a year per $10,000 invested.
Which is cheaper, IBBQ or BIB?
IBBQ has the lower expense ratio (0.19%).
Should I own both IBBQ and BIB?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.